JPMORGAN CHASE & CO - 30 Jun 2025 SCHEDULE 13G/A Report for Radiopharm Theranostics Limited Ordinary Shares, as represented by American Depositary Shares (RADX)

Filing Manager
JPMORGAN CHASE & CO
Reporting Manager
JPMORGAN CHASE & CO.
Security
Radiopharm Theranostics Limited Ordinary Shares, as represented by American Depositary Shares
Symbol
RADX
Shares outstanding
2,449,788,256 shares
Disclosed Ownership
220,480,943 shares
Ownership
9%
Form type
SCHEDULE 13G/A
Filing time
16 Jul 2025, 09:34:25 UTC
Date of event
30 Jun 2025
Previous filing
11 Feb 2025
Next filing
16 Jan 2026
SEC
View on sec.gov

Quoteable Key Fact

"JPMORGAN CHASE & CO disclosed 9% ownership in Radiopharm Theranostics Limited Ordinary Shares, as represented by American Depositary Shares (RADX) on 30 Jun 2025."

Quick Takeaways

  • JPMORGAN CHASE & CO filed SCHEDULE 13G/A for Radiopharm Theranostics Limited Ordinary Shares, as represented by American Depositary Shares (RADX).
  • Disclosed ownership: 9%.
  • Date of event: 30 Jun 2025.

What Changed

  • Previous schedule filing date: 11 Feb 2025.
  • Current filing was accepted on 16 Jul 2025, 09:34.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
JPMORGAN CHASE & CO. 9% 220,480,943 220,480,943 0 Rachel Tsvaygoft Vice President